イノベーションハブ
創薬のライフサイクルにおけるあらゆる段階の最新のブレイクスルー、技術、リソースをご紹介します。
Button Text



Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Biomarkers
Biometrics
HBS
Health Economics & Outcomes Research (HEOR)
Protein Sciences
No items found.
Pharmacology
Cell Culture & Characterization
Toxicology
Crown Bioscience

ブログ
Bridging Discovery & Clinical Translation: InoKey for Biomarker-Driven Drug Development
2月 4, 2025
スポンサー:
スポンサー
ブログを読む
Pharmacology
Protein Sciences
Inoviv
Market Access
No items found.

ブログ
Leveraging Human Pluripotent Stem Cells for Breakthroughs in Drug Discovery for Neuroscience
1月 14, 2025
ブログを読む
Pharmacology
Cell Culture & Characterization
No items found.

ブログ
Assessing the Research Value of Biospecimens for ADC Development With Ki67 Tissue Staining
1月 8, 2025
スポンサー:
スポンサー
ブログを読む
Pharmacology
BioIVT
Biomarkers
Pharmacology
HBS
Indivumed Services
Disease Models
Pharmacology
No items found.
Biomarkers
DNA & RNA
No items found.
Disease Models
Eliala Alice Salvadori
Jason Rogers
Noldus Information Technology
No items found.
Health Economics & Outcomes Research (HEOR)
Danielle Drachmann
Josie Godfrey
Kristine Sørensen
Beth Lesher
Kelly McCarrier
OPEN Health
HealthEconomics.com
Disease Models
DNA & RNA
Cell Culture & Characterization
Eduardo Marbán
No items found.
American Physiological Society
European Council for Cardiovascular Research
Disease Models
Bradley Palmer
IonOptix
American Physiological Society
European Council for Cardiovascular Research
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Real-World Evidence (RWE)
Marija Zivkovic-Gojovic
Richard Pitman
Pragya Khurana
ICON
HealthEconomics.com
Disease Models
Ana Briones
Kent Scientific Corporation
American Physiological Society
European Council for Cardiovascular Research
Real-World Data (RWD)
Clinical Trials
Real-World Evidence (RWE)
Nitin Baliga
Thomas Brown
Syapse
HealthEconomics.com
Disease Models
In Vitro Assays
George Portugal
Harvard Bioscience, Inc.
American Physiological Society
European Council for Cardiovascular Research
Pharmacology
Cell Culture & Characterization
Toxicology
Martin Stahl
STEMCELL Technologies Inc.
Scientist.com

ポッドキャスト
From Data Access to Evidence Usability: Connecting Payer Policy, Real-World Data, and Clinical Context to Close the Evidence Gap
7月 13, 2026
ポッドキャストを読む
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Data (RWD)
Real-World Evidence (RWE)
Real-World Evidence (RWE)
Clinical Trials
Real-World Data (RWD)
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Clinical Trials
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Instrumentation & Products
Trial Insights
Real-World Evidence (RWE)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
Medical Communications
Real-World Evidence (RWE)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Health Economics & Outcomes Research (HEOR)
Real-World Data (RWD)
Health Economics & Outcomes Research (HEOR)
Market Access
Health Economics & Outcomes Research (HEOR)
Market Access
No items found.

































.avif)








